The endgame for serogroup a meningococcal disease in Africa?
- PMID: 23087392
- PMCID: PMC3540039
- DOI: 10.1093/cid/cis896
The endgame for serogroup a meningococcal disease in Africa?
Comment on
-
Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity.Clin Infect Dis. 2013 Feb;56(3):354-63. doi: 10.1093/cid/cis892. Epub 2012 Oct 19. Clin Infect Dis. 2013. PMID: 23087396
References
-
- Greenwood B. Manson lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg. 1999;93:341–53. - PubMed
-
- LaForce FM, Konde K, Viviani S, Preziosi MP. The meningitis vaccine project. Vaccine. 2007;25:A97–100. - PubMed
-
- Sow SO, Okoko BJ, Diallo A, et al. Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans. N Engl J Med. 2011;364:2293–304. - PubMed
-
- Kristiansen PA, Diomande F, Absatou KB, et al. Impact of serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity [published online ahead of print 19 October 2012] Clin Infect Dis. 2013;56:354–63. - PubMed
